Valuation: Gulf Pharmaceutical Industries

Market Cap 1.1B 298M 267M 246M 223M 417M 28.39B 424M 2.94B 1.17B 14.86B 1.12B 47.06B P/E 2026 *
-
P/E 2027 * 7.29x
Enterprise Value 925M 252M 226M 208M 188M 352M 23.99B 358M 2.48B 991M 12.55B 945M 39.76B EV / Sales 2026 *
0.8x
EV / Sales 2027 * 0.7x
Free-Float
34.75%
Yield 2026 *
-
Yield 2027 * -
1 day-0.94%
1 week+1.07%
Current month-7.96%
1 month-8.85%
3 months-8.85%
6 months-9.71%
Current year-18.97%
1 week 0.92
Extreme 0.92
0.97
1 month 0.91
Extreme 0.91
1.07
Current year 0.91
Extreme 0.91
1.26
1 year 0.91
Extreme 0.91
1.47
3 years 0.73
Extreme 0.73
1.78
5 years 0.7
Extreme 0.701
2.04
10 years 0.7
Extreme 0.701
4.51
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 01/01/2017
Director/Board Member - 01/01/2019
Chairman - 01/01/2005
Change 5-day change 1-year change 3-year change Capi.($)
-0.94%+1.07%-22.30%+26.23% 301M
+6.63%+5.13%+68.86%+145.20% 1,148B
+1.53%+2.84%+47.48%+89.01% 652B
+1.68%+1.96%+29.16%+109.31% 505B
+0.73%+2.45%+54.26%+68.96% 384B
+3.83%-0.62%+69.01%+42.32% 348B
+2.38%+2.65%+34.31%+57.95% 294B
+2.26%+0.55%+3.92%+28.92% 264B
+1.97%+3.01%+57.91%+76.14% 244B
+4.03%+5.36%+39.76%+116.14% 197B
Average +2.01%+2.42%+38.24%+76.02% 403.75B
Weighted average by Cap. +2.25%+2.89%+50.21%+95.96%

Financials

2026 *2027 *
Net sales 1.15B 314M 281M 259M 235M 439M 29.87B 446M 3.09B 1.23B 15.63B 1.18B 49.51B 1.24B 338M 303M 279M 253M 472M 32.17B 480M 3.33B 1.33B 16.84B 1.27B 53.33B
Net income 99M 26.95M 24.14M 22.27M 20.16M 37.69M 2.57B 38.3M 266M 106M 1.34B 101M 4.25B 148M 40.29M 36.09M 33.3M 30.13M 56.34M 3.84B 57.25M 397M 158M 2.01B 151M 6.36B
Net Debt -170M -46.28M -41.46M -38.25M -34.61M -64.72M -4.41B -65.76M -456M -182M -2.31B -174M -7.31B -232M -63.16M -56.58M -52.19M -47.23M -88.32M -6.01B -89.75M -623M -248M -3.15B -237M -9.97B
Projected Income Statement - Annual - Gulf Pharmaceutical Industries
Logo Gulf Pharmaceutical Industries
Gulf Pharmaceutical Industries Julphar Co PJSC is a United Arab Emirates based pharmaceutical company. The Company is engaged in manufacturing and selling of medicines, drugs and various other types of pharmaceutical and medical compounds in addition to cosmetic compounds. The Company’s segments include Manufacturing, Planet, Investments. The products of the Company include general medicines, diabetes solutions, cardiovascular care, consumer healthcare products, wound care and dermatology, respiratory and git medicines. The Company’s subsidiaries include mena cool transportation f.z.e., julphar pharmaceuticals p.l.c., julphar ses l.l.c., diabtec l.l.c and others.
Employees
2,400
Date Price Change Volume
29/10/26 AED 0.9480 -0.94% 878,410
28/10/26 AED 0.9570 -1.34% 187,968
27/10/26 AED 0.9700 +2.11% 1,123,677
26/10/26 AED 0.9500 +3.26% 1,776,722
23/10/26 AED 0.9200 -1.92% 1,414,478
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Gulf Pharmaceutical Industries
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9480AED
Average target price
1.720AED
Spread / Average Target
+81.43%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Gulf Pharmaceutical Industries
  1. Stock Market
  2. Stocks
  3. JULPHAR Stock